Diphenhydramine and levofloxacin combination therapy against antimicrobial resistance in respiratory tract infections

被引:10
作者
Areej, Sadaf [1 ]
Sattar, Adeel [1 ]
Javeed, Aqeel [1 ]
Raza, Sohail [2 ]
机构
[1] Univ Vet & Anim Sci, Dept Pharmacol & Toxicol, Lahore, Pakistan
[2] Univ Vet & Anim Sci, Dept Microbiol, Lahore, Pakistan
关键词
antibacterial effect; antimicrobial resistance; combination therapy; cytotoxic evaluation; diphenhydramine; levofloxacin; Pseudomonas aeruginosa; respiratory tract infections; Staphylococcus aureus; synergism;
D O I
10.2217/fmb-2019-0346
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Antibiotics are in use since decades to treat various infections caused by Gram-positive and Gram-negative bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa. Diphenhydramine, an H1 receptor blocker possesses a weak antibiotic action but when combined with other antibiotics may potentiate their antibacterial activity. Materials & methods: This study investigated in vitro antibacterial activity of diphenhydramine when used alone and in combination with levofloxacin against methicillin-resistant S. aureus and P. aeruginosa. Results: The combined antibacterial effect of the drugs against bacteria showed a fractional inhibitory concentration index of <= 0.5, in other words, synergism. No cytotoxicity was observed as percentage cell viability was >50%. Conclusion: The combination of diphenhydramine and levofloxacin exerted antibacterial activity, and was not found to be cytotoxic when given in combination against P. aeruginosa and S. aureus.
引用
收藏
页码:409 / 420
页数:12
相关论文
共 54 条
[1]   β-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative Bacilli [J].
Al-Hasan, Majdi N. ;
Wilson, John W. ;
Lahr, Brian D. ;
Thomsen, Kristine M. ;
Eckel-Passow, Jeanette E. ;
Vetter, Emily A. ;
Tleyjeh, Imad M. ;
Baddour, Larry M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) :1386-1394
[2]  
Alp E., 2016, J INFECT DIS, V4, P1, DOI DOI 10.4172/2332-0877.100028740
[3]  
[Anonymous], MICROBE NOTES CULTUR
[4]   Drug Repurposing and the Medicinal Chemist [J].
Aube, Jeffrey .
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (06) :442-444
[5]   Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis Airways Influences Virulence of Staphylococcus aureus In Vitro and Murine Models of Co-Infection [J].
Baldan, Rossella ;
Cigana, Cristina ;
Testa, Francesca ;
Bianconi, Irene ;
De Simone, Maura ;
Pellin, Danilo ;
Di Serio, Clelia ;
Bragonzi, Alessandra ;
Cirillo, Daniela M. .
PLOS ONE, 2014, 9 (03)
[6]   ANTIBIOTIC RESISTANCE PATTERN IN PSEUDOMONAS AERUGINOSA ISOLATED AT A TERTIARY CARE HOSPITAL [J].
Bhatiani, Ambika ;
Chandna, Ashish .
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (70) :12169-12173
[7]  
Biemer J J, 1973, Ann Clin Lab Sci, V3, P135
[8]   Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution [J].
Bollenbach, Tobias .
CURRENT OPINION IN MICROBIOLOGY, 2015, 27 :1-9
[9]   Multidrug resistance in anaerobes [J].
Boyanova, Lyudmila ;
Markovska, Rumyana ;
Mitov, Ivan .
FUTURE MICROBIOLOGY, 2019, 14 (12) :1055-1064
[10]   Histamine H1 receptor antagonists enhance the efficacy of antibacterials against Escherichia coli [J].
Bruer, G. G. ;
Hagedorn, P. ;
Kietzmann, M. ;
Tohamy, A. F. ;
Filor, V. ;
Schultz, E. ;
Mielke-Kuschow, S. ;
Meissner, J. .
BMC VETERINARY RESEARCH, 2019, 15 (1)